ArticleFrontiers in cardiovascular medicine2022

Efficacy and Safety of Granulocyte-Colony Stimulating Factor Therapy in Chagas Cardiomyopathy: A Phase II Double-Blind, Randomized, Placebo-Controlled Clinical Trial.

Carolina T Macedo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.